Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Change In Inventory : E£31 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Inventory?

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's change in inventory for the quarter that ended in Dec. 2023 was E£65 Mil. It means Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's inventory declined by E£65 Mil from Sep. 2023 to Dec. 2023 .

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's change in inventory for the fiscal year that ended in Dec. 2023 was E£31 Mil. It means Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's inventory declined by E£31 Mil from Dec. 2022 to Dec. 2023 .

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Total Inventories for the quarter that ended in Dec. 2023 was E£303 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Days Inventory for the quarter that ended in Dec. 2023 was 109.34.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.83.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.63.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Inventory Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Inventory Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

58.93

-100.76

47.58

-88.60

30.97

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															5.78	-39.95	-16.66	22.48	65.10

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£31 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	335.6145	/	280.093	*	365 / 4
	=	109.34

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	280.093	/	335.6145
	=	0.83

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	335.6145	/	534.192
	=	0.63

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Inventory Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY

Website

https://www.ramedapharma.com

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines